|MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call|
|By GLOBE NEWSWIRE|
|Thursday, 22 July 2021 11:05|
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE)
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) --
MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the second quarter 2021 after the market closes on Thursday, July 29, 2021. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, July 29, 2021 at 4:30 pm ET. The conference call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the Conference ID# 7983402.
The listen-only webcast of the conference call can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at http://ir.macrogenics.com/events.cfm. A recorded replay of the webcast will be available shortly after the conclusion of the call and archived on the Company's website for 30 days following the call.
About MacroGenics, Inc.
CONTACTS: Christopher James, M.D., Vice President, Investor Relations and Corporate Communications Jim Karrels, Senior Vice President, CFO MacroGenics, Inc. 1-301-251-5172, [email protected]